Jimmy A Rotolo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jimmy A Rotolo

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Nature Medicine|November 12, 2002

T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.

Plos One|July 16, 2011

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023

Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligandsDaniela I Staquicini, Marina Cardó-Vila, Jimmy A Rotolo, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Nature Medicine|November 12, 2002

T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.

Plos One|July 16, 2011

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023

Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligandsDaniela I Staquicini, Marina Cardó-Vila, Jimmy A Rotolo, et al.

Pageof 3